Recent advances in clinical studies and the evolving role of subtyping for patients with diffuse large B-cell lymphoma.
Division of Hematology, Mayo Clinic, Rochester, MN 55902, USA.
Grzegorz S
GS
Nowakowski
Divison of Hematology, Città della Salute e della Scienza Hospital & University, Torino, Italy.
Umberto
U
Vitolo
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D000069286:Bortezomib / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D018572:Disease-Free Survival; D019008:Drug Resistance, Neoplasm / Q000235:genetics; D006801:Humans; D016403:Lymphoma, Large B-Cell, Diffuse / Q000145:classification / Q000188:drug therapy* / Q000235:genetics* / Q000473:pathology; D009363:Neoplasm Proteins / Q000235:genetics*
D009363:Neoplasm Proteins; D000069286:Bortezomib
chemotherapy; hematologic/lymphoma; molecular oncology